Free Trial
NASDAQ:ASRT

Assertio (ASRT) Stock Price, News & Analysis

Assertio logo
$0.73 +0.00 (+0.68%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.74 +0.02 (+2.06%)
As of 08/8/2025 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Assertio Stock (NASDAQ:ASRT)

Key Stats

Today's Range
$0.71
$0.73
50-Day Range
$0.62
$0.77
52-Week Range
$0.51
$1.38
Volume
138,325 shs
Average Volume
215,153 shs
Market Capitalization
$69.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.63
Consensus Rating
Buy

Company Overview

Assertio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

ASRT MarketRank™: 

Assertio scored higher than 37% of companies evaluated by MarketBeat, and ranked 720th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Assertio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Assertio has only been the subject of 2 research reports in the past 90 days.

  • Read more about Assertio's stock forecast and price target.
  • Earnings Growth

    Earnings for Assertio are expected to grow in the coming year, from ($0.15) to $0.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Assertio is -2.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Assertio is -2.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Assertio has a P/B Ratio of 0.57. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Assertio's valuation and earnings.
  • Percentage of Shares Shorted

    5.87% of the outstanding shares of Assertio have been sold short.
  • Short Interest Ratio / Days to Cover

    Assertio has a short interest ratio ("days to cover") of 21.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Assertio has recently decreased by 4.10%, indicating that investor sentiment is improving.
  • Dividend Yield

    Assertio does not currently pay a dividend.

  • Dividend Growth

    Assertio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.87% of the outstanding shares of Assertio have been sold short.
  • Short Interest Ratio / Days to Cover

    Assertio has a short interest ratio ("days to cover") of 21.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Assertio has recently decreased by 4.10%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Assertio this week, compared to 1 article on an average week.
  • Search Interest

    7 people have searched for ASRT on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Assertio to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Assertio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.00% of the stock of Assertio is held by insiders.

  • Percentage Held by Institutions

    48.96% of the stock of Assertio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Assertio's insider trading history.
Receive ASRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Assertio and its competitors with MarketBeat's FREE daily newsletter.

ASRT Stock News Headlines

Assertio Holdings Earnings Preview
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Assertio Holdings, Inc. (ASRT) - Yahoo Finance
See More Headlines

ASRT Stock Analysis - Frequently Asked Questions

Assertio's stock was trading at $0.8711 at the beginning of 2025. Since then, ASRT stock has decreased by 16.3% and is now trading at $0.7290.

Assertio Holdings, Inc. (NASDAQ:ASRT) released its earnings results on Monday, May, 12th. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.08. The firm had revenue of $26.49 million for the quarter, compared to the consensus estimate of $27.52 million. Assertio had a negative trailing twelve-month return on equity of 24.87% and a negative net margin of 25.72%.
Read the conference call transcript
.

Assertio's top institutional shareholders include Geode Capital Management LLC (1.07%). Insiders that own company stock include Daniel A Peisert, Heather L Mason, William Mckee, Jeff L Vacirca, Ajay Patel, Sam Schlessinger, Paul Schwichtenberg and Brendan P O'grady.
View institutional ownership trends
.

Shares of ASRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Assertio investors own include Plug Power (PLUG), FuelCell Energy (FCEL), Workhorse Group (WKHS), Fortress Biotech (FBIO), KALA BIO (KALA), Lipocine (LPCN) and Ovid Therapeutics (OVID).

Company Calendar

Last Earnings
5/12/2025
Today
8/10/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ASRT
CIK
1808665
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$3.50
Low Price Target
$1.75
Potential Upside/Downside
+260.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.58 million
Net Margins
-25.72%
Pretax Margin
-25.59%
Return on Equity
-24.87%
Return on Assets
-10.87%

Debt

Debt-to-Equity Ratio
0.36
Current Ratio
1.66
Quick Ratio
1.35

Sales & Book Value

Annual Sales
$124.96 million
Price / Sales
0.56
Cash Flow
$0.05 per share
Price / Cash Flow
14.85
Book Value
$1.27 per share
Price / Book
0.57

Miscellaneous

Outstanding Shares
95,780,000
Free Float
91,950,000
Market Cap
$69.82 million
Optionable
Optionable
Beta
0.28

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ASRT) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners